Literature DB >> 25102471

Desmodeleganine, a new alkaloid from the leaves of Desmodium elegans as a potential monoamine oxidase inhibitor.

Kang-Kang Zhi1, Zhong-Duo Yang2, Dan-Feng Shi3, Xiao-Jun Yao4, Ming-Gang Wang1.   

Abstract

Desmodeleganine (1), a new potential monoamine oxidase inhibitor, along with three known alkaloids, bufotenin (2), hydroxy-N, N-dimethyltryptamine N(12)-oxide (3), 2-(5-methoxy-1H-indol-3-yl)-N, and N-dimethylethylamine (4) were isolated from the leaves of Desmodium elegans. Their structures were elucidated by IR, MS, 1D and 2D NMR spectra. 1 showed strong monoamine oxidase inhibitory activity with IC50 value of 13.92 ± 1.5 μM, when the IC50 value of iproniazid as a standard was 6.5 ± 0.5 μM. The molecular modeling was also performed to explore the binding mode of compounds 1, 2 at the active site of MAO-A and MAO-B.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Alkaloids; Desmodium elegans; Monoamine oxidase; Monoamine oxidase inhibitors

Mesh:

Substances:

Year:  2014        PMID: 25102471     DOI: 10.1016/j.fitote.2014.07.022

Source DB:  PubMed          Journal:  Fitoterapia        ISSN: 0367-326X            Impact factor:   2.882


  4 in total

Review 1.  Natural Products Inhibitors of Monoamine Oxidases-Potential New Drug Leads for Neuroprotection, Neurological Disorders, and Neuroblastoma.

Authors:  Narayan D Chaurasiya; Francisco Leon; Ilias Muhammad; Babu L Tekwani
Journal:  Molecules       Date:  2022-07-04       Impact factor: 4.927

2.  Soyasapogenol-B as a Potential Multitarget Therapeutic Agent for Neurodegenerative Disorders: Molecular Docking and Dynamics Study.

Authors:  Danish Iqbal; Syed Mohd Danish Rizvi; Md Tabish Rehman; M Salman Khan; Abdulaziz Bin Dukhyil; Mohamed F AlAjmi; Bader Mohammed Alshehri; Saeed Banawas; Qamar Zia; Mohammed Alsaweed; Yahya Madkhali; Suliman A Alsagaby; Wael Alturaiki
Journal:  Entropy (Basel)       Date:  2022-04-23       Impact factor: 2.738

3.  3D-QSAR and in-silico Studies of Natural Products and Related Derivatives as Monoamine Oxidase Inhibitors.

Authors:  Priyanka Dhiman; Neelam Malik; Anurag Khatkar
Journal:  Curr Neuropharmacol       Date:  2018       Impact factor: 7.363

Review 4.  1H Nuclear Magnetic Resonance: A Future Approach to the Metabolic Profiling of Psychedelics in Human Biofluids?

Authors:  Sylvana Vilca-Melendez; Malin V Uthaug; Julian L Griffin
Journal:  Front Psychiatry       Date:  2021-12-13       Impact factor: 4.157

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.